About us

IBSA Group is a Swiss multinational pharmaceutical Company, founded in 1945 in Lugano. Today, its products are present in over 90 Countries on 5 continents, through the Company’s 20 subsidiaries located in Europe, China, and the United States.

IBSA Group employs over 2,300 people between headquarters, subsidiaries and production sites. IBSA holds 90 families of approved patents, plus others under development, as well as a vast portfolio of products, covering 10 therapeutic areas: reproductive medicine, endocrinology, pain and inflammation, osteoarticular, aesthetic medicine, dermatology, urogynecology, cardiometabolic, respiratory, and consumer health. With a strong global presence, it plays a leading role in reproductive medicine and continues to set benchmarks in hyaluronic acid-based therapies.

IBSA has based its philosophy on four pillars: Person, Innovation, Quality and Responsibility.  

IBSA established a presence in the United States as IBSA USA in 2018 to expand access to its innovative treatments for hypothyroidism and pain management.  IBSA USA is committed to bringing other innovative therapeutic products to the United States market.

VISION

IBSA places the Person – including their health and well-being – at the center of its work. Making drugs in the best form, while outlining new treatment perspectives, is the goal that IBSA has always pursued. The company’s commitment is characterized by the creation of innovative pharmaceutical forms and administration systems of proven efficacy, which really improve the prospects of care and the quality of life of patients. Technology and Innovation, Culture and Education, Communication and Sustainability are the milestones in IBSA’s path, which has been plotted with the aim of never setting limits and keep innovating, while maintaining People at the heart of the company’s ecosystem. 

MISSION

IBSA is committed to improving the quality of life of patients through the research and development of effective drugs and technologies that are more in keeping with people’s health needs as well as qualitatively transforming already known therapeutic solutions. What drives the company is the patient, not the market. Cutting-edge technologies, innovation and creativity come together to develop pharmaceutical products capable of responding to people’s ever-growing needs. Designed to be aimed not only at their care, but also at the improvement of their health and well-being. IBSA is committed to returning value to the communities where it operates in a responsible, ethical and sustainable manner.